Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Svare

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Diabetes, Obesity & Metabolism|November 10, 2025
Five years liraglutide treatment improves glucose tolerance in women with previous gestational diabetes mellitus-Results from a randomised controlled trialEmilie S Andersen, Signe Foghsgaard, Louise Vedtofte, et al.
Diabetes, Obesity & Metabolism|October 17, 2023
Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: A 52-week randomized controlled clinical trialSigne Foghsgaard, Louise Vedtofte, Emilie S Andersen, et al.
Diabetes Care|November 5, 2016
Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist CircumferenceSigne Foghsgaard, Camilla Andreasen, Louise Vedtofte, et al.
Journal of Clinical Medicine|October 10, 2020
One Year's Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled TrialLouise Vedtofte, Emilie Bahne, Signe Foghsgaard, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Diabetes, Obesity & Metabolism|November 10, 2025
Five years liraglutide treatment improves glucose tolerance in women with previous gestational diabetes mellitus-Results from a randomised controlled trialEmilie S Andersen, Signe Foghsgaard, Louise Vedtofte, et al.
Diabetes, Obesity & Metabolism|October 17, 2023
Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: A 52-week randomized controlled clinical trialSigne Foghsgaard, Louise Vedtofte, Emilie S Andersen, et al.
Diabetes Care|November 5, 2016
Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist CircumferenceSigne Foghsgaard, Camilla Andreasen, Louise Vedtofte, et al.
Journal of Clinical Medicine|October 10, 2020
One Year's Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled TrialLouise Vedtofte, Emilie Bahne, Signe Foghsgaard, et al.
Pageof 3